VIR-7229
Product Specifications
Target
Influenza Virus|||SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
VIR-7229 is a human IgG1 monoclonal antibody that targets the Receptor-Binding Domain (RBD) of the Spike glycoprotein. It exhibits antiviral activity by competing with ACE2 for binding and inducing the shedding of the S1 protein. VIR-7229 is applicable for research on SARS-CoV-2 infections. Recommended isotype control: Human IgG1 kappa, Isotype Control.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1291884-01 0.02 mg (E-Coli)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus Xaa-Pro dipeptidase (pepQ)
Ask
View Details MBS1291884-02 0.02 mg (Yeast)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus Xaa-Pro dipeptidase (pepQ)
Ask
View Details 
MBS1291884-03 0.1 mg (E-Coli)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus Xaa-Pro dipeptidase (pepQ)
Ask
View Details 
MBS1291884-04 0.1 mg (Yeast)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus Xaa-Pro dipeptidase (pepQ)
Ask
View Details 
MBS1291884-05 0.02 mg (Baculovirus)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus Xaa-Pro dipeptidase (pepQ)
Ask
View Details MBS1291884-06 0.02 mg (Mammalian-Cell)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus Xaa-Pro dipeptidase (pepQ)
Ask
View Details